Passa al contenuto
Merck
  • Discovery of simplified benzazole fragments derived from the marine benzosceptrin B as necroptosis inhibitors involving the receptor interacting protein Kinase-1.

Discovery of simplified benzazole fragments derived from the marine benzosceptrin B as necroptosis inhibitors involving the receptor interacting protein Kinase-1.

European journal of medicinal chemistry (2020-07-14)
Mohamed Benchekroun, Ludmila Ermolenko, Minh Quan Tran, Agathe Vagneux, Hristo Nedev, Claire Delehouzé, Mohamed Souab, Blandine Baratte, Béatrice Josselin, Bogdan I Iorga, Sandrine Ruchaud, Stéphane Bach, Ali Al-Mourabit
ABSTRACT

With the aim to develop new chemical tools based on simplified natural metabolites to help deciphering the molecular mechanism of necroptosis, simplified benzazole fragments including 2-aminobenzimidazole and the 2-aminobenzothiazole analogs were prepared during the synthesis of the marine benzosceptrin B. Conpounds inhibiting the RIPK1 protein kinase were discovered. A library of 54 synthetic analogs were prepared and evaluated through a phenotypic screen using the inhibition of the necrotic cell death induced by TNF-α in human Jurkat T cells deficient for the FADD protein. This article reports the design, synthesis and biological evaluation of a series of 2-aminobenzazoles on the necroptotic cell death through the inhibition of RIPK1 protein kinase. The 2-aminobenzimidazole and 2-aminobenzothiazole platforms presented herein can serve as novel chemical tools to study the molecular regulation of necroptosis and further develop lead drug candidates for chronic pathologies involving necroptosis.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Staurosporina, for molecular biology, ≥95% (HPLC)
Sigma-Aldrich
Histone from calf thymus, Type III-S
Sigma-Aldrich
Indirubin-3′-oxime, ≥98% (HPLC), solid
Sigma-Aldrich
CHR-6494 trifluoroacetate salt, ≥98% (HPLC)